Elias Jabbour, MD; Jae Park, MD; Jerald P. Radich, MD

How Can We Be More Strategic in Treatment Planning for Patients with ALL?

Saad Z. Usmani, MD, MBA, FACP; Surbhi Sidana, MD; Carlyn R. Tan, MD 

Managing Multiple Myeloma From Newly Diagnosed to Relapsed/Refractory Settings: An Expert Case-Based Discussion

Elias Jabbour, MD; Hagop M. Kantarjian, MD; Shilpa Paul, PharmD, BCOP

Navigating Treatment Options for CML Across the Disease Continuum: An Expert Case-Based Discussion

Mikkael A. Sekeres, MD; Amy DeZern, MD, MHS; Rami S. Komrokji, MD; Bhumika Patel, MD

Community Practice Connections™: Exploring Current and Emerging Data Sets to Move Treatment of Higher-Risk MDS Forward: A Focus on Novel Targets and Treatment Approaches

Balazs Halmos, MD, MS; Lynette M. Sholl, MD; Yelena Y. Janjigian, MD

Community Practice Connections™: 5th Annual International Congress on Oncology & Pathology™: Towards Harmonization of Pathology and Oncology Standards

Peter Martin, MD; Jonathon B. Cohen, Md MS; Kami Maddocks, MD; Elizabeth Budde, MD, PhD

Medical Crossfire®: How are the Experts Applying the Latest Advances for Patients with Mantle Cell Lymphoma?

Oncology Briefings™: Optimizing Care in Oncogene-Driven Advanced NSCLC

Rita R. Alloway, PharmD; Daniel Brennan, MD; E. Steve Woodle, MD, FACS

Community Practice Connections™: Let's Get “Real”: Minimizing Allograft Rejection in Renal Transplantation – Applying the Evidence to Real-World Scenarios

Kevin Winthrop, MD, MPH; David E. Griffith, MD

Patient, Provider, & Caregiver Connection™: Patient Perspectives in Non-Tuberculous Mycobacteria Lung Disease

James A. Underberg, MD, MS, FACPM, FACP, FNYAM, FASPC, FNLA

Advances in™ Cardiology: Emerging Treatments for Hypercholesteremia in Statin Intolerant Patient Populations: What Options Do You Have?

Oncology Briefings™: Analyzing the Evidence of Biosimilars in HER2-Positive and Supportive Breast Cancer Care Settings

Srdan Verstovsek, MD, PhD; Andrew Kuykendall, MD; Raajit K. Rampal, MD, PhD; Abdulraheem Yacoub, MD

Advances in MF and PV: Individualizing Care Based on Patient- and Disease-Specific Factors

Paul G. Richardson, MD; Meral Beksac, MD; Graham Jackson, MA, MB, BS, MD; Katja Christina Weisel, MD

A NEW WAVE OF PROGRESS IN  RELAPSED/REFRACTORY MULTIPLE MYELOMA: Global Perspectives on Antibody-Based Treatment Strategies

Naval G. Daver, MD; Christian A. Laubscher, MHS, PA-C

Patient, Provider & Caregiver Connection™: Addressing Patient Concerns During the Treatment and Management of Higher-Risk MDS

Peter P. Toth, MD, PhD, FCCP, FASPC, FAHA, FESC, FACC; Harold Edward Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC; Pam R. Taub, MD, FACC, FASPC

Community Practice Connections™: Utilizing Real-World Evidence to Optimize Outcomes in Type 2 Diabetes – Reducing Cardiovascular Disease & CV Risk

Grzegorz S. Nowakowski, MD; Christopher R. Flowers, MD, MS, FASCO; Andre H. Goy, MD, MS; Kami J. Maddocks, MD; Laurie H. Sehn, MD, MPH

Community Practice Connections™: Illustrated Case Discussions: Practical Approaches to Treating Relapsed/Refractory DLBCL in 2021

Community Practice Connections™: Uncovering New Multiple Myeloma Therapies and Their Clinical Applications: Antibodies, CARs, BiTEs, and Beyond

Edward S. Kim, MD; Yelena Y. Janjigian, MD; Oliver Sartor, MD; Joyce O’Shaughnessy, MD

Community Practice Connections™: ASCO Direct Highlights: Practice-Changing Data From The Leading Oncology Conference

Burst Expert Illustrations and Commentaries™: Visualizing Gene Therapy Approaches in Hemophilia A

Jason Bacharach, MD; Inder Paul Singh, MD, MPH

(COPE Credit) Expert Illustrations & Commentaries™: Visualizing the Role of Nitric Oxide in Glaucoma COPE Credit

(CME/CNE Credit) Expert Illustrations & Commentaries™: Visualizing the Role of Nitric Oxide in Glaucoma

Francis S. Mah, MD; Preeya K. Gupta, MD; Edward J. Holland, MD; Stephen C. Pflugfelder, MD

(COPE Credit) Medical Crossfire®: Expert Perspectives in Neurotrophic Keratitis – Updates in Optimal Treatment Strategies & Emphasizing Importance of Early Intervention 

(CME/CNE Credit) Medical Crossfire®: Expert Perspectives in Neurotrophic Keratitis – Updates in Optimal Treatment Strategies & Emphasizing Importance of Early Intervention

Janet B. Serle, MD; Jody R. Piltz-Seymour, MD

Cases and Conversations in Glaucoma Care – Effectively Lowering IOP with Rho Kinase Inhibition

Arshad M. Khanani, MD, MA; Sophie J. Bakri, MD; Peter K Kaiser, MD; Carl D. Regillo, MD

Medical Crossfire®: Expert Perspectives in Sustained Delivery of Anti-VEGF Therapies – Understanding How Novel Treatments May Shift the Paradigm

Francis S. Mah, MD; Selina R. McGee, OD, FAAO

(COPE Credit) Expert Illustrations & Commentaries: Visualizing Therapies on the Horizon for Presbyopia

(CME/CNE Credit) Expert Illustrations & Commentaries: Visualizing Therapies on the Horizon for Presbyopia

Community Practice Connections™: Show Me the Data®: Evidence-Based Strategies to Leverage Immunogenicity in Hepatocellular Carcinoma

Advances in™: Assessing the Impact of Recent Advances for the Management of Chronic GVHD

Megan Hinkley, PharmD, BCOP; Meg Taylor, PharmD, CPP

Updates in Therapeutic Strategies for Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach to Optimal Management of Adverse Effects, featuring Counseling Vignettes

Emanuele Zucca, MD; Massimo Federico, MD; Pier Luigi Zinzani, MD, PhD 

Medical Crossfire®: How the Experts Manage Advanced HL and PTCL in the Real World from Frontline to R/R Treatment Settings

Brett King, MD, PhD; Brittany Craiglow, MD

An Animated View of Alopecia Areata to Advance Our Approaches to Patient Management

Cancer Summaries and Commentaries™: Investigating Key Updates for the Treatment and Management of AML and MDS

22nd Annual International Congress on the Future of Breast Cancer® West

Charu Aggarwal, MD, MPH; Dara Aisner, MD, PhD; Balazs Halmos, MD, MS; Julia Kathleen Rotow, MD; David R. Gandara, MD

Community Practice Connections™: Top 10 Oncogenic Markers in NSCLC for 2022: Evolution of Tumor Testing Technologies, Novel Treatments, and Trials!

Scott Tagawa, MD, MS, FACP; Alicia Morgans, MD, MPH; Michael J. Morris, MD

Medical Crossfire®: Key Questions on Sequencing, Radioligands, and Novel Emerging Approaches in CRPC

Sara A. Hurvitz, MD, FACP; Aditya Bardia, MD, MPH

Community Practice Connections™: Incorporating Novel HER2-Targeted Therapies Into Treatment Algorithms Across Metastatic Breast Cancer

Robert L. Coleman, MD, FACOG, FACS; Ursula A. Matulonis, MD; Bradley J. Monk, MD, FACS, FACOG; Kathleen Moore, MD

Community Practice Connections™: 13th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™

Narjust Duma, MD; Coral Olazagasti, MD; Gilberto de Lima Lopes, MD, MBA, FASCO; Ana Maria López, MD, MPH, MACP, FRCP;  Vonetta M. Williams, MD, PhD

Working Group™: Strategies for Recognizing and Taking Steps to Address Disparities in Cancer Care Among Diverse Populations

Benjamin P. Levy, MD; David R. Gandara, MD; Aparna R. Parikh, MD, MS; Heather A. Parsons, MD, MPH

Community Practice Connections™:  Analyzing the Evolving Role of Liquid Biopsies Across Cancer Care

Jessica Michaud Davis, PharmD, BCOP, CPP; Robert L. Ferris, MD, PhD; Kristi K Orbaugh, MSN, NP, AOCNP

Optimizing Immune Checkpoint Inhibitors in Early-Stage Cancer Treatment Through Multidisciplinary Collaboration

24th Annual International Lung Cancer Congress®

Clinical Vignettes™: Testing and Treatment Strategies in Cholangiocarcinoma

James L.M. Ferrara, MD, DSc; Carrie L. Kitko, MD

Community Practice Connections™: Incorporating Novel Therapies Into Treatment Algorithms Across Acute and Chronic GVHD

Advanced Renal Cell Carcinoma: Tyrosine Kinase Inhibitors Versus Immune Checkpoint Inhibitors

Sandra Kurtin, PhD, ANP-BC, AOCN; Ravi Vij, MD, MBA; Kathryn Maples, PharmD, BCOP

Advances In: Interprofessional Strategies to Optimize Outcomes for Patients with Relapsed/Refractory Multiple Myeloma: Expert Discussions to Maximize Safety and Efficacy

Clement L. Ren, MD, MBA, ATSF; Samya Nasr, MD, CPI, ATSF; George M. Solomon, MD

Clinical Consultations™: Optimizing Treatment Outcomes for Patients With Cystic Fibrosis

BURST CME™: Exploring the Biologic Rationale for Novel IRAK4-directed Therapy for the Treatment of High Risk MDS and AML 

Bradley J. Monk, MD, FACS, FACOG; Lucy Gilbert, MD, MSc, FRCOG; Bhavana Pothuri, MD, MS; Matthew A. Powell, MD

Medical Crossfire®: How Are We Personalizing Integration of ICIs and Targeted Therapies to Optimize Outcomes in Endometrial Cancer?

Jeff Unger, MD, FAAFP, FACE;  Jennifer D. Goldman, PharmD, RPh, CDCES, BC-ADM, FCCP; Carrie McAdam-Marx, PhD, RPh; Brittany Hoffmann-Eubanks, PharmD, MBA; Angel A. Rodriguez, PharmD; Lori A. Uildriks, PharmD, BCPS, BCGP; Jeannette Y. Wick, RPh, MBA, FASCP

Analyzing the Value of Continuous Glucose Monitoring in Diabetes Care and Overcoming Barriers Through Expanded Pharmacy Access

Virtual Show Me the Data™: How HER2, HER3, and TROP2 Targeted Strategies Will Impact Evolving Paradigms in NSCLC

Caring for Patients on CAR T-Cell Therapy in the Inpatient Versus Outpatient Setting

Advances In™: The Role of NRG1 Fusions Across Tumor Types

Tiffany A. Traina, MD; Odessa Williams, AGPCNP-BC; Latasha Jordan; Nicole Badgett

Patient, Provider, and Caregiver Connection™: Addressing Patient Concerns During the Treatment and Management of TNBC

Terry P. Mamounas, MD, MPH, FACS; Joyce O’Shaughnessy, MD; David M. Euhus, MD, FACS

Community Practice Connections™: Navigating Adjuvant Decision-Making for High-Risk Early-Stage Hormone Receptor-Positive Breast Cancer

Christopher R. Flowers, MD, MS, FASCO; Frederick L. Locke, MD; Kami J. Maddocks, MD; Laurie H. Sehn MD, MPH

Hot Seat™: Expert Considerations to Maximize the Clinical Benefits of Targeted Therapies in Patients With Relapsed/Refractory DLBCL

Aditya Bardia, MD, MPH; Erika P. Hamilton, MD; Komal Jhaveri, MD, FACP; Nicholas Turner, MD, PhD 

  Medical Crossfire®: Evaluating the Potential Role of Next-Generation Selective Estrogen Receptor Degraders in the ER+/HER2- Breast Cancer Treatment Paradigm

Jonathan I. Silverberg, MD, PhD, MPH, FAAD; Peck Y. Ong, MD


Individualizing Treatment in Moderate-to-Severe Atopic Dermatitis through Improved Clinician-Patient Communication

Edward B. Garon, MD, MS; Lyudmila Bazhenova, MD; Solange Peters, MD, PhD; Zofia Piotrowska, MD, MHS

Medical Crossfire®: Leveraging EGFR Mutation Profiles to Personalize Therapeutic Decisions in Resected and Metastatic NSCLC Settings

Ruben A. Mesa, MD, FACP ; Jamile M. Shammo, MD, FASCP, FACP ; Naveen Pemmaraju, MD 

Expert Illustrations and Commentaries™: Placing New MPN Therapies Into Context Through Illustrated Case Discussions

Robert Dreicer, MD, MS, MACP, FASCO; Tomasz Beer, MD, FACP; Scott Tagawa, MD, MS, FACP; Tanya Dorff, MD

How Guidelines and Recent Clinical Trial Data Inform the Modern-Day Treatment of Advanced Prostate Cancer

Dawn A. Laney, MS, CGC; Eric Wallace, MD, FASN

Clinical ConsultationsTM: Focusing on Fabry Disease in Females: Individualizing Diagnostic and Counseling Plans to Improve Long-Term Outcomes

Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; Leah Smith, MSN, APRN, FNP-BC, CNN-NP, FNKF; Catherine Wells, DNP, ACNP, CNN-NP, FNKF

Cases and Conversations: Individualizing Diabetes Care in the Management of Chronic Kidney Disease: Developing the Optimal Treatment Plan With Your Patient

John Rhodes, MD; Robert J. Sommer, MD; Christine A. Holmstedt, DO

Medical Crossfire: Optimizing Outcomes for Patients with Stroke: Secondary Prevention and Risk Reduction

Reflective Case-Based Oncology Collective™: Translating Recent Evidence to the Real-World Management of Acute Lymphoblastic Leukemia

Susanna V Ulahannan, MD, MMEd; Manish Patel, MD


Expert Illustrations & Commentaries™: The Role of B7-H3 Across Tumor Types and How It Could Impact Your Practice in the Future

Jeffrey Laurence, MD; Mitchell S. Cairo, MD; Vincent T. Ho, MD; Sonata Jodele, MD

New Perspectives in HSCT-TMA: Driving the Future of Diagnosis and Treatment

Nursing Management of Relapsed/Refractory Multiple Myeloma in an Era of Expanding Options

Cases and Conversations™: Nursing Considerations for the Management of ER+ Breast Cancer

Luciano J. Costa, MD, PhD; Paul Shaughnessy, MD

Optimizing ASCT in Patients With Multiple Myeloma and Non-Hodgkin Lymphoma Through Stem Cell Mobilization Techniques

Onco-Nurse Academy™: Exploring an Advent of Targeted Therapies Across Advanced NSCLC Care and Strategies for Managing Adverse Events Associated with Treatment

Anita Afzali, MD, MPH, MHCM; Marla C. Dubinsky, MD; Christina Ha, MD, FACG, AGAF

Optimizing Care in Inflammatory Bowel Disease (IBD): The Role of Emerging Therapies in Improving Patient Outcomes

Jane S. Davis, CRNP, DNP; Jean Colaneri, ACNP-BC, CNN-NP

Community Practice Connections™: Expert Illustrations and Commentaries: Nephrology Nurse Perspectives in Anemia in CKD

Genovefa Papanicolaou, MD; Guenther Koehne, MD, PhD; Roy F. Chemaly, MD, MPH, FIDSA, FACP; Sanjeet Dadwal, MD, FACP, FIDSA

Community Practice Connections™: Evolving Paradigms in Transplant-Related CMV Prevention and Management: Setting Foundations for Improved Patient Outcomes

CAR T-Cell Therapy in Multiple Myeloma: Key Considerations for Patient Selection, Transplant, and Applying Recent Data

Evolving Paradigms in Transplant-Related CMV Prevention and Management: Setting Foundations for Improved Patient Outcomes

Burst CME: Improving Outcomes for Your Patient with Vitiligo

Elizabeth Verna, MD, MSc; Arun B. Jesudian, MD

Clinical Consultations™: Facilitating Optimal Treatment Outcomes and Multidisciplinary Care in Hepatorenal Syndrome- Acute Kidney Injury (HRS-AKI)

Burst Expert Illustrations & Commentaries™: Management Strategies for Refractory Ascites

Elizabeth Verna, MD, MSc; Lisa B. VanWagner, MD, MSc, FAST, FAHA

Advances In™ Cirrhosis: Reframing the Management of Hepatorenal Syndrome-Acute Kidney Injury: A Review of Current Strategies

Evaluating the Evolution of CKD Treatment: What’s New and How Can We Incorporate It? 

Burst Expert Illustrations & Commentaries™: Current Treatments for Esophageal Variceal Hemorrhage

Anemia of Chronic Kidney Disease: Improving Recognition and Early Treatment in the Primary Care Setting

Matthew Lunning, DO, FACP; Yi Lin, MD, PhD

Community Practice Connections™: Translating Recent Evidence on CAR T-Cell Therapy to the Real-World Management of Lymphoid Malignancies

Corey S. Cutler, MD, MPH; Catherine Lee, MD

Expert Illustrations & Commentaries™: Exploring the Rationale for Emerging Mechanistic Approaches in cGvHD

Reflective Case Based Oncology Collective™: Incorporating Novel HER2- Targeted Therapies into Treatment Algorithms Across Metastatic Breast Cancer

Reflective Case Based Oncology Collective™: Incorporating Novel Therapies into Treatment Algorithms Across Acute and Chronic GvHD

Fátima Cardoso, MD; Mario Campone, MD, PhD; Giuseppe Viale, MD, FRCPath

Tumor Board: How The Experts Approach Personalized Care Plans in ER-Positive Breast Cancer

Pasi A. Jänne, MD, PhD; Jason Chang, MD; Gregory Riely, MD, PhD; Beth Sandy, MSN, CRNP

Medical Crossfire®: Multidisciplinary Discussions on the Application of Novel EGFR exon 20 Targeted Regimens for NSCLC Management

Naval G. Daver, MD; Guillermo Garcia-Manero, MD; Uma Borate, MD, MS; Jacqueline S. Garcia, MD

Reshaping Higher-Risk MDS Patient-Centered Care with Emergence of Novel Evidence and Clinical Trials

Charu Aggarwal, MD, MPH; Dara Aisner MD, PhD; D. Ross Camidge, MD, PhD; Balazs Halmos, MD, MS; Julia Kathleen Rotow, MD

Top 10 Oncogenic Markers in NSCLC for 2022: Evolution of Tumor Testing Technologies, Novel Treatments, and Trials!

Krishna Komanduri, MD; Juan Ramirez, APRN-BC; Charalambos Andreadis, MD; Laura J. Zitella, NP, MSN

Community Practice Connections™: Optimally and Safely Integrating Novel Therapies Across the DLBCL Care Spectrum

Michael A. Choti, MD; John L. Marshall, MD; Christopher Lieu, MD; Manish A. Shah, MD

Community Practice Connections™: 7th Annual School of Gastrointestinal Oncology®

Leonard G. Gomella, MD, FACS; Primo N. Lara Jr, MD; Daniel P. Petrylak, MD

Community Practice Connections™: 15th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

Charles Vega, MD, FAAFP; Sandeep Nathan, MD, MS; Maja Zaric, MD

Community Practice Connections™: Venous Thromboembolism: Patient-Centric and Guideline-Directed Strategies for Optimal Coordinated Care.

Show Me Your Care Plan! Nursing Strategies to Support Continuity of Care in the Treatment of Multiple Sclerosis

Sundar Jagannath, MD, FASCO; Nikhil Munshi, MD

Oncology Consultations™: Coordinating Care for Patients with Multiple Myeloma Between CAR T Centers of Excellence and the Oncology Community

Hope S. Rugo, MD, FASCO; Kevin Kalinsky, MD, MS; Terry P. Mamounas, MD, MPH, FACS; Sara M. Tolaney, MD, MPH

Continuing Education

Latest News